​

Funding Round

Series C - MBX Biosciences

Series C - MBX Biosciences

Investment Firm

Overview

MBX Biosciences is a preclinical-stage biotech company that creates therapies to treat rare endocrine diseases.

Announced Date

Aug 05, 2024

Funding Type

Series C

Highlights

Location

United States, North America

Social

Investor Lead

Deep Track Capital

Deep Track Capital

Deep Track Capital is a post_ipo and private_equity firm.

Participant Investors

9

Investor Name
Participant InvestorOrbiMed
Participant InvestorT. Rowe Price
Participant InvestorWellington Management
Participant InvestorNew Enterprise Associates
Participant InvestorNorwest Venture Partners

Round Details and Background

MBX Biosciences raised $63500000 on 2024-08-05 in Series C

MBX Biosciences is a preclinical-stage biotech company that creates therapies to treat rare endocrine diseases.

Company Funding History

4

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Apr 25, 2019
Debt Financing - MBX Biosciences
-25.3M
Jul 27, 2020
Series A - MBX Biosciences
6-34.6M
Nov 14, 2022
Series B - MBX Biosciences
6-115.0M
Aug 05, 2024
Series C - MBX Biosciences
9-63.5M

Recent Activity

There is no recent news or activity for this profile.